Explore our technologies and learn more about CRISPR genome engineering benefits, techniques, and more.
CRISPR therapies are revolutionizing medicine, making up 70% of current gene-editing trials. To accelerate the clinical development of CRISPR cell and gene therapies, Synthego has launched its new, state-of-the-art manufacturing facility. This flyer provides an insight into our new manufacturing capacity for the production of GMP-grade CRISPR sgRNAs.
Explore Synthego's high-fidelity novel nuclease, hfCas12Max and how it can accelerate the development of CRISPR-based therapeutics.
Discover the essentials of CRISPR therapies with our concise guide to the Chemistry, Manufacturing, and Controls (CMC), Critical Quality Attributes (CQAs), and the Common Technical Document (CTD).
Revolutionize the future of medicine with CRISPR cell and gene therapies! Download our informative flyer to uncover how Synthego can help navigate the complex regulatory landscape surrounding these innovative therapies.
Synthego has applied our expertise in CRISPR genome editing to produce high-quality research-grade gRNAs for basic research, pre-clinical in vitro studies, and early CRISPR-based therapeutic development. In this flyer, learn...
Synthego has applied our expertise in CRISPR genome editing to produce gRNAs specific for your IND-enabling studies in preparation for your IND submission. In this flyer, learn more about our...
Synthego has applied our expertise in CRISPR genome editing to produce GMP-grade synthetic sgRNA. In this flyer, learn more about our GMP-grade sgRNAs including the process, documentation, and state-of-the-art facility...
Synthego is your trusted partner for CRISPR gene editing. With our comprehensive range of sgRNA quality options—large-scale RUO, INDe, and GMP—we are poised to help guide your CRISPR-based research successfully...
T cells are a key component of the adaptive immune system. Both chimeric antigen receptor (CAR) and T cell receptor (TCR) immunotherapies have been clinically approved to treat various blood...
Plasmid and virus-mediated delivery is a common way to introduce CRISPR-Cas9 editing machinery into cells. Sorting the edited cells from unmanipulated ones often requires selectable markers. Unfortunately, the use of...
Choosing the right guide RNA format is an important step in the CRISPR workflow. Traditional formats, such as plasmids and lentivirus, are time-consuming and laborious to produce. Researchers spend seven...
Cart
Account
Your Orders
Sign In